PRFX

PRFB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

15%

Probability

Target price

$1.80

+50.0% vs current

Most likely

Base case

45%

Probability

Target price

$1.10

-8.3% vs current

B-

Bear case

40%

Probability

Target price

$0.55

-54.2% vs current

AI sentiment snapshot

Latest data as of 2026-07-21

AI commentary

The latest checked company release on July 15, 2026 added a DeepSolar product expansion, while the June 25 release provided directionally constructive but preclinical PRF-110 data. These issuer-supplied updates do not establish a clinical or commercial inflection. Analyst revisions, target changes, and post-release price-reaction attribution remain unavailable. With a $1.15 anchor price and a deterministic neutral prior, this remains a low-conviction monitoring view.

RankAlpha Sentiment Codex - 2026-07-21

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-06-25eventPRF-110 expanded preclinical benchmark dataHigh impact

PRF reported comparable analgesic efficacy to ZYNRELEF in a porcine post-operative pain model, with slower absorption and enhanced local tissue retention. The data support further development but do not establish clinical efficacy, approval, or commercialization. [#PR-EARNINGS-2026-06-25]

2026-09-30eventOcuRing-K Phase II enrollment milestoneHigh impact

The company previously said FDA clearance of the OcuRing-K IND enabled a U.S. Phase II cataract-surgery trial, with enrollment expected in the second half of 2026. This remains an enrollment step rather than efficacy proof. [#PR-2026-04-28]

2026-10-19eventDeepSolar platform expansion toward planned launchHigh impact

PRF announced a DeepSolar Predict expansion adding battery-to-revenue intelligence and said the solution was advancing toward planned commercial launch. The update does not establish material revenue or customer conversion. [#PR-2026-07-15]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-21 • Updated nightlySource: Internal modelMethodology